Preclinical Evaluation of a Lead Specific Chelator (PSC) Conjugated to Radiopeptides for 203Pb and 212Pb-Based Theranostics
与放射性肽结合的铅特异性螯合剂 (PSC) 对基于 203Pb 和 212Pb 的治疗诊断学的临床前评估
期刊:Pharmaceutics
影响因子:4.9
doi:10.3390/pharmaceutics15020414
Mengshi Li, Nicholas J Baumhover, Dijie Liu, Brianna S Cagle, Frédéric Boschetti, Guillaume Paulin, Dongyoul Lee, Zhiming Dai, Ephraim R Obot, Brenna M Marks, Ibrahim Okeil, Edwin A Sagastume, Moustafa Gabr, F Christopher Pigge, Frances L Johnson, Michael K Schultz